>
Fa   |   Ar   |   En
   Enzymatically modified low-density lipoprotein is present in all stages of aortic valve sclerosis: Implications for pathogenesis of the disease  
   
نویسنده twardowski l. ,cheng f. ,michaelsen j. ,winter s. ,hofmann u. ,schaeffeler e. ,müller s. ,sonnenberg m. ,steuer k. ,ott g. ,schwab m. ,franke u.f.w. ,torzewski m.
منبع journal of the american heart association - 2015 - دوره : 4 - شماره : 10
چکیده    Background: we have demonstrated previously that enzymatically degraded low-density lipoprotein (eldl) is an essential causative component for the initiation of atherosclerosis. here,we investigated the different stages of human aortic valve sclerosis for the presence of eldl and effectors of the innate immune system,as well as the interaction of eldl with isolated valvular interstitial cells/myofibroblasts to discover possible pathways leading to aortic valve sclerosis. methods and results: human aortic valvular tissue was obtained from 68 patients undergoing valve replacement surgery. patients were classified into 3 groups (mild,moderate,or severe aortic valve sclerosis),and clinical data for statistical analysis were gathered from all patients. immunohistochemical staining demonstrated extensive extracellular deposits of eldl throughout all grades of aortic valve sclerosis. complementary analysis of lipid composition revealed higher concentrations of the decisive components of eldl (ie,unesterified cholesterol and linoleic acid) compared with internal control tissues. further,the complement component c3d and terminal complement complexes colocalized with eldl compatible with the proposal that subendothelially deposited eldl is enzymatically transformed into a complement activator at early stages of valvular cusp lesion development. gene expression profiles of proteases and complement components corroborated by immunohistochemistry demonstrated an upregulation of the protease cathepsin d (a possible candidate for ldl degradation to eldl) and the complement inhibitor cd55. surprisingly,substantial c-reactive protein expression was not observed before grade 2 aortic valve sclerosis as investigated with microarray analysis,reverse transcription-polymerase chain reaction analysis,and immunohistochemistry. finally,we demonstrated cellular uptake of eldl by valvular interstitial cells/myofibroblasts. conclusions: the present study is a startup of a hypothesis on the pathogenesis of aortic valve sclerosis declaring extracellular lipoprotein modification,subsequent complement activation,and cellular uptake by valvular interstitial cells/myofibroblasts as integral players. © 2015 the authors.
کلیدواژه Aortic valve stenosis; C-reactive protein; Low-density lipoprotein
آدرس departments of laboratory medicine,robert-bosch-hospital,stuttgart, Germany, departments of laboratory medicine,robert-bosch-hospital,stuttgart,germany,dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, departments of cardiovascular surgery,robert-bosch-hospital,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany, departments of pathology,robert-bosch-hospital,stuttgart, Germany, dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart,germany,department of clinical pharmacology,university hospital,tuebingen, Germany, departments of cardiovascular surgery,robert-bosch-hospital,stuttgart, Germany, departments of laboratory medicine,robert-bosch-hospital,stuttgart,germany,dr. margarete fischer-bosch institute of clinical pharmacology,university of tuebingen,stuttgart, Germany
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved